Trial · NCT03548935
Adverse events344
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 344
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal distension | Gastrointestinal disorders | Sema 2.4 mg | 96 | 1,306 | 135 |
| other | Abdominal distension | Gastrointestinal disorders | Placebo | 31 | 655 | 42 |
| other | Abdominal pain | Gastrointestinal disorders | Sema 2.4 mg | 127 | 1,306 | 172 |
| other | Abdominal pain | Gastrointestinal disorders | Placebo | 36 | 655 | 41 |
| other | Abdominal pain upper | Gastrointestinal disorders | Sema 2.4 mg | 125 | 1,306 | 176 |
| other | Abdominal pain upper | Gastrointestinal disorders | Placebo | 35 | 655 | 37 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Sema 2.4 mg | 81 | 1,306 | 92 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 43 | 655 | 47 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Sema 2.4 mg | 106 | 1,306 | 120 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 53 | 655 | 55 |
| other | Constipation | Gastrointestinal disorders | Sema 2.4 mg | 305 | 1,306 | 389 |
| other | Constipation | Gastrointestinal disorders | Placebo | 62 | 655 | 73 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Sema 2.4 mg | 40 | 1,306 | 45 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Placebo | 33 | 655 | 35 |
| other | Decreased appetite | Metabolism and nutrition disorders | Sema 2.4 mg | 124 | 1,306 | 139 |
| other | Decreased appetite | Metabolism and nutrition disorders | Placebo | 22 | 655 | 26 |
| other | Diarrhoea | Gastrointestinal disorders | Sema 2.4 mg | 411 | 1,306 | 765 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 104 | 655 | 138 |
| other | Dizziness | Nervous system disorders | Sema 2.4 mg | 98 | 1,306 | 129 |
| other | Dizziness | Nervous system disorders | Placebo | 23 | 655 | 35 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03548935/events